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GABAA receptors that contain the a5 subunit (a5GABAARs) are highly expressed in the hippocampus, and
have been implicated in learning and memory processes. They generate a tonic form of inhibition that
regulates neuronal excitability. Recently it was shown that a5GABAARs also contribute to slow phasic
inhibition of CA1 pyramidal neurons following local stimulation in the stratum lacunosum moleculare.
However, it is unknown whether a5GABAARs can also be recruited indirectly by stimulation of Schaffer
collaterals. Here, we studied GABAergic currents evoked by stimulation in the stratum radiatum of CA1 in
the presence and absence of CNQX to block AMPA receptor-mediated excitation. We tested their
sensitivity to gabazine and two drugs acting at the benzodiazepine site of a1/a2/a3 or a5GABAARs
(400 nM zolpidem and 20 nM L-655,708, respectively). IPSCs evoked by stimulation in the stratum
radiatum in the presence of CNQX were potentiated by zolpidem, blocked by 1 mM gabazine and were
relatively insensitive to L-655,708 consistent with the lack of a5GABAARs. In contrast, IPSCs evoked by
stimulation of Schaffer collaterals had a signiﬁcant gabazine-insensitive component. This component
was attenuated by L-655,708 and enhanced by burst stimulation. Furthermore, the L-655,708-sensitive
current was absent in recordings from mice lacking a5GABAARs (gabra5/ mice). These results show
that a5GABAAR-mediated phasic inhibition is activated by the Schaffer collateral pathway and provide
evidence for activity pattern-dependent participation of a5GABAARs in inhibition.
 2009 Elsevier Ltd. Open access under CC BY license. 1. Introduction
Synaptic inhibition in the hippocampus plays a crucial role
in balancing and synchronising the activity of excitatory cells.
g-aminobutyric acid (GABA) released by inhibitory interneurons
activates GABAA receptors (GABAARs), and in most mature neurons,
GABA causes a reduction of the postsynaptic cell excitability via
hyperpolarising and/or shunting inhibition (for review, see Mann
and Paulsen, 2007). GABAARs are Cl permeable, pentameric ionic
channels that are formed from the combination of distinct subunits160, þ44 (0) 7975 623 420
. Vargas-Caballero).
 license.  (a1e6, b1e3, g1e3, d, 3, q, p, r1e3), and the majority of native
combinations identiﬁed to date have a common 2:2:1 a/b/g stoi-
chiometry (reviewed in Wafford, 2005).
The targeting of pyramidal cells by inhibitory interneurons
follows a highly organised pattern, and the vast majority of
GABAergic interneurons target either the perisomatic or speciﬁc
dendritic domains of pyramidal cells (Klausberger and Somogyi,
2008). However, the role of speciﬁc GABAAR subtypes expressed in
distinct CA1 pyramidal cell compartments is still poorly understood.
There is some evidence of a high correlation between presynaptic
interneuron type and their speciﬁc GABAARs subunit targets (Nusser
et al., 1996; Thomson et al., 2000). For example, in the neocortex,
recordings from synaptically-connected pairs between GABAergic
interneurons and pyramidal cells have demonstrated that dendritic
targeting inhibitory neurons preferentially activate a5GABAARs,
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Thomson, 2008).
By identifying the GABAAR subtypes in different inhibitory
pathways, it may be possible to pharmacologically target speciﬁc
GABAergic networks in the hippocampus. Recent studies have
started to dissect the contribution of GABAARs subtypes to different
behaviours. Pharmacological tools in this area include the use of
benzodiazepine derivatives or genetic modiﬁcations targeted at the
benzodiazepine site, which is located at the interface of g2 and
a subunits (reviewed in Wafford, 2005). By altering the kinetics of
single GABAAR channels, benzodiazepines enhance the effect of
GABA and a behavioural readout can be obtained to interpret the
function of targeted a subunits. For example, mice with a point
mutation in the a1GABAAR subunit (His101Arg), which rendered it
insensitive to diazepam, did not display the sedative and amnestic
effects of benzodiazepines (McKernan et al., 2000; Rudolph et al.,
1999). Conversely, inverse agonists acting at the benzodiazepine site
(Tenen and Hirsch,1980) inhibit the effect of GABA, and have effects
opposite to those of the classical benzodiazepines. Using this
approach, systemic application of the a3 inverse-agonist a3IA
promoted anxiety-related behaviours in rodents (Atack et al., 2005).
a5GABAARs are of particular interest as they are highly
expressed in the adult hippocampus both at synaptic and extra-
synaptic sites (Sperk et al., 1997; Sur et al., 1999), in stark contrast to
low expression levels in other brain areas. Consistent with their
hippocampal localisation, behavioural studies using a5 subunit-
speciﬁc inverse agonists and a5 subunit knock out mice strongly
implicated a5GABAARs in the modulation of learning and memory
(Collinson et al., 2002; Atack et al., 2006; Ballard et al., 2009).
Therefore, a5GABAARs are currently considered as relevant targets
for memory blocking drugs (Martin et al., 2009) and cognitive
enhancing drugs with clinical applications such as in Alzheimer's
disease patients, whose a5GABAARs are well preserved (Howell
et al., 2000). However, the precise mechanisms underlying the
regulation of hippocampal function by a5GABAARs are not known.
It is well established that extrasynaptic a5GABAARs can mediate
a large component of tonic inhibition in the hippocampus (Caraiscos
et al., 2004; Scimemi et al., 2005; Glykys and Mody, 2006; Prenosil
et al., 2006). In contrast, the role of a5GABAARs in phasic inhibition
remains poorly understood. Studies comparing spontaneous and
locally-evoked inhibition between mice lacking a5GABAARs
(gabra5/) and wild type (WT) mice suggested a negligible
contribution of a5GABAARs to phasic inhibition (Collinson et al.,
2002; Glykys and Mody, 2006). Other studies have suggested that
a5GABAARs mediate a slowly decaying component of synaptic
inhibition (GABAA,slow) (Prenosil et al., 2006; Zarnowskaet al., 2009).
Evoked GABAA,slow potentials have only been observed following
local extracellular stimulation at or near the stratum lacunosum
moleculare (SLM) of the hippocampus (Pearce, 1993; Ouardouz and
Lacaille, 1997; Zarnowska et al., 2009). Thus, GABAA,slow has been
proposed tomodulate the activityof distal dendrites in hippocampal
CA1 pyramidal neurons, and to mediate a component of synaptic
inhibition activated by the direct input from the entorhinal cortex to
the hippocampus at the SLM (Banks et al., 2000).
In order to understand the underlying mechanisms of
a5GABAARs targeting cognitive enhancing drugs, it becomes
important to establish whether in addition to their SLM activation,
a5GABAARs are recruited by CA3 output via Schaffer collateral
activity. Local stimulation at the stratum radiatum (SR) in CA1 has
been reported to produce fast decaying IPSCs via perisomatic tar-
geting inhibitory cells (Ouardouz and Lacaille, 1997) mediated by
a1/a2/a3GABAARs (Thomson et al., 2000). However, under condi-
tions of local stimulation, excitatory synaptic transmission is
usually blocked with glutamate receptor antagonists. Feed-forward
inhibition requires activation of afferent ﬁbres to interneuronswhich in turn release GABA onto pyramidal cells (Alger and Nicoll,
1982). The Schaffer collaterals are likely to stimulate directly or
indirectly a wide variety of interneurons that would not be reached
by local stimulation. In the present study, we compared locally-
evoked and Schaffer collateral-stimulated inhibitory currents. To
determine whether a5GABARs contribute to the evoked IPSCs we
used the inverse-agonist L-655,708 in rats and gabra5/mice. The
results show that stimulation of Schaffer collaterals can activate
a slowly decaying component of GABAergic inhibition, mediated by
a5 subunit-containing GABAA receptors, particularly following
bursts of high-frequency stimulation of Schaffer collateral afferent
input.
2. Methods
Animals were housed in groups with access to food and water ad libitum. The
holding facilities maintained a temperature of approximately 22 C, humidity of
60e70%, and a 12-h light/dark cycle. All animal care and experimental procedures
were in accordance with the UK Home Ofﬁce regulations under the Animals
(Scientiﬁc Procedures) Act of 1986, and the Animal Care Committee of the University
of Toronto.
2.1. Tissue preparation
Parasagittal slices containing the hippocampus were obtained from male
Sprague Dawley rats (supplied by Harlan, Bicester, UK), or from gabra5/ mice
(Collinson et al., 2002) andwild type (WT) littermates ranging from postnatal day 14
to 28. Rodents were anaesthetized with 5% isoﬂuorane until breathing slowed down
to approximately one breath per second, and stimulation of the limb withdrawal
reﬂex no longer elicited a response. After decapitation, the brain was quickly
removed into ice-cold artiﬁcial cerebrospinal ﬂuid (aCSF), containing (in mM): NaCl,
126; KCl, 2.5; NaHCO3, 26; CaCl2, 2; MgCl2, 2; NaH2PO4, 1.25; glucose, 10, saturated
with 95% O2/5% CO2, with a ﬁnal pH of 7.2e7.4. Slices were prepared at 350 mm
thickness using a Leica VT1000S microtome. Slices containing the hippocampal
formation were trimmed from other brain regions and were maintained and
recorded at room temperature (22e27 C).
2.2. Electrophysiological recordings
After transferring a single slice to a submerged-style recording chamber,
a monopolar stainless steel stimulation electrode (A-M Systems, Sequim, WA, USA)
was placed into the SR of CA1 50e100 mm away from the stratum pyramidale (SP) for
synaptic stimulation. Stimulation in the SR was carried out under two different
conditions: ﬁrstly, to record GABAA,local, AMPA receptor-mediated excitation was
blockedwith CNQXwhile recording from a pyramidal cell. The stimulation electrode
was placed approximately 100 mm lateral to the recorded cell to ensure stimulation
of local interneurons. Secondly, to record inhibition elicited by the Schaffer collat-
erals (GABAA,SC) CNQX was not included. The stimulation electrode was placed
approximately 300 mm lateral to the recorded cell to reduce local stimulation of
GABAergic neurons in addition to afferent stimulation.
Experiments were performed in voltage clamp mode. The intracellular solution
contained (in mM): Gluconic acid 70; CsCl 10; NaCl 5; BAPTA free acid 10; Hepes 10;
QX-314 10; GTP 0.3; Mg-ATP 4; pH was titrated to 7.25  0.05 with CsOH. The
estimated ﬁnal Cs concentration for the intracellular solution was w120 mM. The
ﬁnal osmolarity was 280  5 mOsmol l1. BAPTA was used to prevent Ca2þ
dependent changes while measuring synaptic activity at depolarised membrane
potentials. QX-314 blocks GABAB receptor-mediated currents in addition to Naþ
channels (Nathan et al., 1990). All voltage values were corrected for the liquid
junction potential measured as 13 mV.
Whole-cell patch clamp recordings were obtained with 2e4 MU borosilicate
pipettes from putative CA1 pyramidal cells identiﬁed by their location in the SP and
by their shape.
The calculated ECl at room temperature was 56 mV, and AMPA receptor-
mediated currents reversed near 0 mV. For this reason GABAergic currents were
recorded at 0 mV, both for local and Schaffer collateral stimulation, so as to isolate
them from AMPA receptor-mediated currents in the latter case. For recordings at
voltages other than70mV, a voltage step from70mV to the test potential started
5 s before synaptic stimulation. Whole-cell recordings were made using an Axon
Multiclamp 700B ampliﬁer (Molecular Devices, Union City, CA, USA). Recordings
were low-pass ﬁltered at 2 kHz and digitised at 20 kHz with a National Instruments
A/D board (Austin, TX, USA) using Ginj 1.0 software (courtesy of Hugh P. C. Robinson)
for acquisition from within Matlab (Mathworks Ltd, Natick, MA, USA). Postsynaptic
currents were evoked using a stimulus isolator unit (ISO-ﬂex, A.M.P.I. Jerusalem,
Israel) which delivered pulses of 100 ms duration in current mode; stimulation
intensities ranged between 20 mA and 70 mA and the computer-controlled stimu-
lation interval was 60 s. Drugs were applied after a stable baseline of 6e10 min
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Series resistance was measured before each stimulation with a 5 mV, 50 ms step
pulse. Recordings were terminated if series resistance (16 6MU) changed bymore
than 20%.
2.3. Data analysis
Data analysis was done using Matlab. Statistical testing was done using Matlab
and SPSS software. Charge transfer was calculated by integrating the current
responses from 5 to 750 ms following synaptic stimulation after leak subtraction (or
5e35 ms and 50e750 ms to separate early and late components in Fig. 1Ci). For
comparison across experiments, synaptic peak current values or total charge
transfer were normalised relative to the mean of baseline values obtained 5 min
before drug application. For statistical comparison of drug effects, the average value
of the last 4 min of recording was used. Data are presented as mean standard error
of the mean (SEM) and are displayed in two-minute bin intervals. N values refer to
the number of slices recorded. Example traces are the average of 3e5 traces
(Gaussian-ﬁltered at a corner frequency of 2 kHz). Statistical signiﬁcance was
assessed using Student's two-sample two-tailed t-test, one-way ANOVA or repeated
measures (RM) ANOVA, with Bonferroni post-hoc corrections for multiple
comparisons where appropriate. P < 0.05 was considered statistically signiﬁcant.
2.4. Drugs
20 mM DL-2-amino-5-phosphonopentanoic acid was used to block N-methyl-
D-aspartic acid (NMDA) receptors in all experiments. CNQX (6-cyano-7-nitro-
quinoxaline-2,3-dione disodium) was used to block AMPA receptor-mediated
synaptic transmission for local stimulation of GABAergic interneurons. Gabazine
(SR 95531 hydrobromide; 6-imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic
acid hydrobromide) is a competitive antagonist at GABAARs. L-655,708 (11,12,13,13a-Fig. 1. Locally-evoked and Schaffer collateral-stimulated GABAAR-mediated currents are d
GABAAR currents evoked by synaptic stimulation in two different recording conditions. Top t
and GABAA,SC. Bottom traces: Synaptic currents recorded at different holding potentials betw
stimulated currents (holding potentials of 70, 50, 30, 10, þ10 and þ40 mV) and curre
mediated components (n ¼ 5). Currents were measured at times indicated by vertical lines in
gabazine. (Bi) Concentrationeresponse plot for GABAA,local and GABAA,SC. Response is the cha
gabazine-resistant component of GABAA,SC. Inset: Example traces of Schaffer collateral-stim
current traces, with and without 1 mM gabazine. Normalised traces for GABAA,local, GABAA,SC
of GABAA,SC elicited with burst stimulation (3 stimuli at 100 Hz). GABAA,SC(5e35 ms) and GA
after stimulation. (Cii) Example traces of GABAA,SC(burst) recorded at 0 mV with and withoutetrahydro-7-methoxy-9-oxo-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-
1-carboxylic acid, ethyl ester) is a partial inverse agonist at the benzodiazepine
binding site of a5GABAAR; L-655,708 was initially dissolved to 10 mM in 1 N HCl,
then diluted to 10 mM by adding H2O, and stored in frozen aliquots until used. Zol-
pidem (N,N,6-trimethyl-2-(4-methylphenyl)imidazol[1,2-a]pyridine-3-acetamide)
is a benzodiazepine acting primarily at a1GABAAR, and with some afﬁnity for a2/
a3GABAAR at 400 nM. Zolpidem was dissolved at 100 mM in ethanol, frozen in
aliquots, and diluted in aCSF just before use; equivalent amounts of ethanol were
added in corresponding control experiments. All drugs described above were
purchased from Tocris (Bristol, UK). Other chemicals were purchased from Sigma
Aldrich (St. Louis, MO, USA).3. Results
To measure synaptic GABAAR-mediated currents in CA1 pyra-
midal neurons in hippocampal slices, single cells were voltage
clamped and brief extracellular stimuli delivered in the SR. First, to
activate local GABAergic currents (referred to as GABAA,local), AMPA
receptor-mediated excitation was blocked using 10 mM CNQX.
GABAA,local reversed close to ECl at 54  3 mV (n ¼ 5; data not
shown; for example traces see Fig. 1Ai) and was seen as an outward
current at 0 mV. At this holding potential, IPSCs had a time constant
of decay (sdecay) of 163  16 ms (n ¼ 12).
Next, IPSCs were elicited by stimulating the Schaffer collaterals.
For these recordings, CNQX was omitted from the extracellular
solution. Biphasic responses comprising both glutamatergic andifferentially sensitive to gabazine. (Ai) Current traces showing voltage dependence of
races: inhibitory currents recorded at 0 mV; GABAA,local in the presence of 10 mM CNQX
een 80 and þ40 mV in steps of 20 mV. (Aii) Expanded traces for Schaffer collateral-
nt voltage relationship for estimated AMPAR (inverted triangles) and GABAAR (squares)
example traces. (B, C) GABAAR currents in the presence of increasing concentrations of
rge transfer normalised to pre-gabazine control values. GABAA,SC(gz) indicates the 1 mM
ulated currents in 1 mM gabazine with holding potentials as in Ai. (Bii) Superimposed
, and GABAA,SC(gz). (Ci) Concentrationeresponse plot for the early and late components
BAA,SC(50e750 ms) were the measured charge transfers in the indicated time windows
t gabazine. Normalised traces on the right. Scale bars in Bi-ii and Cii: 250 ms, 400 pA.
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the slowly decaying inhibitory current was fully blocked by 10 mM
gabazine leaving only a fast decaying AMPA current blocked by
10 mM CNQX). The excitatory component reversed near 0 mV as
expected, and the inhibitory component reversed at 45  1 mV
(n ¼ 5; Fig. 1Aii). The isolated GABAAR-mediated component was
recorded at a holding potential of 0 mV (referred to as GABAA,SC,
Fig. 1Ai). The decay time was signiﬁcantly longer than that for
GABAA,local (GABAA,SC, sdecay ¼ 277  29 ms, n ¼ 10; t-test,
P< 0.001). The ratio of current observed at 500 ms over 15 ms after
stimulation (I500ms/I15ms) showed that GABAA,local current had
decayed to approximately 5% of its peak value after 500 ms,
while a substantial fraction of GABAA,SC could still be observed
(GABAA,local, I500ms/I15ms ¼ 0.05  0.01, n ¼ 11; GABAA,SC, I500ms/
I15ms ¼ 0.32  0.06, n ¼ 6; t-test, P < 0.001).
Both GABAA,local and GABAA,SC decayed signiﬁcantly faster at
70 mV than at 0 mV (sdecay ¼ 70  5 ms, n ¼ 11, and 180  10 ms,
n ¼ 6, respectively, t-test for both, P < 0.01). The slower decay of
GABAA,local and GABAA,SC at 0 mV is consistent with previous
reports showing that GABAAR currents decay more slowly at
depolarised potentials as receptors unbind agonist at a slower rate
(Mellor and Randall, 1998; Burgard et al., 1999). The currents
observed at 70 mV were slower than those reported in some
previous studies. Two factors might have contributed to the slower
kinetics observed in our experiments: the use of BAPTA and the use
of Cs-gluconate. Slower IPSC decay has been observed both during
recording with BAPTA (Banks and Pearce, 2000) and with
Cs-gluconate (Stepanyuk et al., 2002).
a5GABAARs are widely expressed in the SR subﬁeld of the
hippocampal CA1 area (Sperk et al., 1997; Sur et al., 1999), however
their synaptic contribution has not been observed while stimu-
lating locally in the SR. We therefore asked whether a5GABAARs
can contribute to GABAA,SC. As a ﬁrst pharmacological approach we
tested the gabazine sensitivity of GABAAR currents, as it has been
previously reported that a tonic inhibitory conductance mediated
by a5GABAARs is resistant to 1 mM gabazine (Bai et al., 2001;
Caraiscos et al., 2004).
To compare the gabazine sensitivity of locally-evoked and
Schaffer collateral-stimulated currents, IPSCs were recorded in the
presence of increasing concentrations of gabazine (Fig. 1Bi). GABAA,
local currents were abolished by 1 mM gabazine (initial amplitude,
863  144 pA, n ¼ 11) while a signiﬁcant fraction of GABAA,SC
remained under these conditions (19  3% of GABAA,SC of control
charge transfer remaining in 1 mM gabazine; n ¼ 6, initial ampli-
tude, 1261  57 pA). This component is referred to as GABAA,SC(gz)
Example traces are shown in Fig. 1Bii.
The time from stimulation to peak (Table 1) was signiﬁcantly
different for GABAA,local, GABAA,SC, and GABAA,SC(gz) (one-way
ANOVA; F2,21 ¼ 128; P < 0.001; post-hoc P < 0.01 for all compari-
sons). Both GABAA,SC and GABAA,SC(gz) showed slower kinetics
compared to GABAA,local (Table 1, 10e90% rise time; one-way
ANOVA; F2,21¼51; P< 0.001; post-hoc P< 0.05 for all comparisons).
The longer time-to-peak seen for GABAA,SC(gz) was additionally due
to longer latency (Table 1, time fromstimulus to 10%amplitude; one-
way ANOVA; F2,21 ¼ 75; P < 0.001; post-hoc comparisons, GABAA,
SC(gz) versus GABAA,local and GABAA,SC(gz) versus GABAA,SC, both
P < 0.001; GABAA,local versus GABAA,SC, P ¼ 0.22).Table 1
Time-to-peak and rise time for GABAAR currents (in ms).
Time-to-peak
(stimulus to peak)
Time from stimulus
to 10% amplitude
Time from 10 to
90% amplitude
GABAA,local 17  1.8 4.1  0.1 7.5  0.3
GABAA,SC 32  3.1 7.8  0.3 14.2  0.8
GABAA,SC(gz) 75  3.5 27.4  1.1 30  0.9As bursting input from the Schaffer collateral could be necessary
for the ﬁring of dendritic targeting interneurons (Maccaferri and
Dingledine, 2002), we next asked whether bursting activity in this
pathway could enhance GABAA,SC(gz). Indeed this component
became prominent with burst stimulation (3e4 stimuli at 100 Hz)
as 49  7% of inhibitory charge transfer remained in 1 mM gabazine
(Fig. 1Ci). Remarkably, the early component (5e35 ms after stim-
ulation) of burst responses was almost as sensitive to 1 mM gaba-
zine as GABAA,local (fraction remaining in 1 mM gabazine: GABAA,
local, 0.41%, n¼ 6; GABAA,SC (burst, 5e35ms), 15%, n¼ 6; t-test,
P¼ 0.73; example traces in Fig. 1Cii). A signiﬁcant effect of gabazine
inhibition was observed for all recording conditions (GABAA,local,
GABAA,SC and GABAA,SC(burst); RM ANOVA. Charge transfer as the
between-subjects factor, and dose as within-subject factor;
F2,19 ¼ 25; P < 0.001; post-hoc comparisons showed that at 1 mM
gabazine, each group was different from the others, P < 0.001).
To test whether a5GABAARs contribute to the inhibitory
currents described above we next investigated the effect of
L-655,708, which is an inverse-agonist selective for a5GABAAR
subunits in rats, mice and humans at concentrations below 20 nM
(Atack et al., 2006). After a stable baseline recording, 20 nM
L-655,708 was added to the extracellular solution. The effects of
L-655,708 on charge transfer and peak amplitude were estimated
for GABAA,local, GABAA,SC and GABAA,SC(gz), with either single or
burst stimulation for GABAA,SC(gz) (Fig. 2A). In all conditions, the
average charge transfer after addition of L-655,708 was signiﬁ-
cantly different from baseline, but stronger effects were observed
for GABAA,SC(gz) for both single and burst stimulation (percentage
of reduction: GABAA,local, 13  5%, n ¼ 7; GABAA,SC, 12  5%, n ¼ 9;
GABAA,SC(gz) (single), 30  2%, n¼ 6; GABAA,SC(gz) (burst), 33 3%,Fig. 2. The a5 inverse-agonist L-655,708 inhibits GABAA,SC(gz). (A) Superimposed
example traces of GABAAR currents before (grey) and after (black) application of L-
655,708. (B) Normalised charge transfer (i) and peak current (ii) measured during
baseline and after bath application of L-655,708 at time ¼ 0. ***P < 0.001.
Fig. 4. GABAA receptor-mediated currents in gabra5/ mice and WT mice are differ-
entially sensitive to 1 mM gabazine. (A) Superimposed example traces of GABAA,SC
currents before (grey) and after (black) application of 1 mM gabazine. Recordings from
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GABAA,SC(gz) (single) (t-test, P < 0.01), but did not reach signiﬁ-
cance for GABAA,SC(gz) (burst) (t-test, P ¼ 0.07).
To corroborate our ﬁndings on the effects of L-655,708 on
GABAAR-mediated currents, and to test the speciﬁcity of L-655,708
for a5GABAARs, we next used gabra5/ mice and WT littermate
control mice (Collinson et al., 2002). In this set of experiments,
GABAA,SC currents from WT mice showed a signiﬁcant reduction
from baseline following application of 20 nM L-655,708 (GABAA,SC,
33  4% reduction, n ¼ 5; GABAA,SC(gz), 36  4% reduction, n ¼ 7;
t-test, P < 0.001 for both), whereas L-655,708 did not signiﬁcantly
alter the charge transfer for GABAA,SC and GABAA,SC(gz) currents in
gabra5/ slices (Fig. 3A, B; GABAA,SC, n ¼ 7; t-test, P ¼ 0.11; GABAA,
SC(gz), n ¼ 7; t-test, P ¼ 0.20).
We additionally tested whether L-655,708 could be used as
a selective inhibitor of a5GABAARs at concentrations higher than
20 nM during our recording conditions. We found that L-655,708 at
1 mM concentration, and even at concentrations as low as 50 nM,
inhibited the GABAAR current in WT mice to a similar extent to
that seen in gabra5/ mice (no signiﬁcant difference WT versus
gabra5/, n¼ 7 and n¼ 5, respectively: 50 nM, P¼ 0.33, and 1mM,
P ¼ 0.16; Fig. 3C), suggesting that L-655,708 is not selective for
a5GABAARs at concentrations above 20 nM, and thus limiting the
selective inhibition of the a5GABAAR-mediated current to no more
than w30%. Further analysis to compare GABAA,SC currents recor-
ded from WT and gabra5/ mice revealed that the fraction of
GABAA,SC charge transfer that persisted after the application of 1 mM
gabazine was larger in WT mice than in gabra5/mice (34.4  4%,
n¼ 11 versus 20.6 2%, n¼ 10, respectively, t-test, P< 0.01; Fig. 4Ai,
Aii, Bi). Also, the peak current was signiﬁcantly different between
gabra5/ and WT mice (t-test, P < 0.05; Fig. 4Ai, Aii, Bii).Fig. 3. L-655,708 (20 nM) is speciﬁc for the GABAA receptor a5 subunit. (A) Super-
imposed example traces of GABAA,SC (i) and GABAA,SC(gz) (ii) before and after appli-
cation of 20 nM L-655,708 in wild type and gabra5/ mice. (B) Normalised values for
GABAAR charge transfer measured during baseline and following application of
L-655,708 at time 0 for GABAA,SC (i) and GABAA,SC(gz) (ii). (C) Concentration-response
plot of GABAA,SC for 20, 50 and 1000 nM L-655,708 in wild type and gabra5/ mice.
***P < 0.001.
WT (i), and gabra5/ mice (ii). (B) Normalised values for charge transfer (i) and peak
current (ii) measured during baseline and following application of 1 mM gabazine at
time 0. *P < 0.05; **P < 0.01.Finally, to test whether the GABAAR currents described above
are mediated in part by a1/a2/a3GABAARs receptors we tested the
effects of 400 nM zolpidem (Fig. 5). As expected, zolpidem
increased the charge transfer of GABAA,local currents (48  6%,
n ¼ 7). Also, both GABAA,SC and GABAA,SC(gz) charge transfer was
enhanced (GABAA,SC by 33.3  4%, n ¼ 5, and GABAA,SC(gz) by
16  5%, n ¼ 5; Fig. 5A, B). Zolpidem had a signiﬁcantly different
effect on currents under all recording conditions (GABAA,local,
GABAA,SC and GABAA,SC(gz); one-way ANOVA, F2,32 ¼ 21.6,
P < 0.001; post-hoc comparisons with signiﬁcant differences as
shown in Fig. 5Bi).
A slight increase in peak amplitude from baseline values was
observed in all three recording conditions with no signiﬁcant
difference among them (Fig. 5Bii). The large increase in charge
transfer and small change in peak amplitude in response to zolpi-
dem have been previously observed for miniature postsynaptic
potentials (Perrais and Ropert, 1999). In total, our results suggest
that a5GABAARs contribute signiﬁcantly to GABAA,SC.4. Discussion
Previouswork investigating the subunit composition of synaptic
GABAA receptors has measured spontaneous or stimulus-evoked
GABAergic inhibition in the hippocampus while blocking gluta-
matergic excitation. In the present study, we describe the distinct
pharmacology of locally-evoked versus Schaffer collateral-stimu-
lated GABAAR currents. GABAA,local currents were eliminated by
1 mM gabazine and were markedly enhanced by 400 nM zolpidem,
whereas GABAA,SC currents were less sensitive to 1 mM gabazine
Fig. 5. The enhancing effect of zolpidem is larger on GABAA,local and GABAA,SC than on
GABAA,SC(gz). (A) Superimposed example traces of GABAAR currents before and after
application of zolpidem (400 nM). From left to right: GABAA,local, GABAA,SC, and GABAA,
SC(gz) with corresponding symbols in B. (B) Normalised values of charge transfer (i)
and peak current (ii) measured during baseline and following application of zolpidem
at time 0. Signiﬁcant difference of charge transfers but not peak currents between
baseline and the last 4 min of recording for the three recording conditions. *P < 0.05;
***P < 0.001.
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showed the greatest reduction by L-655,708 and was relatively
insensitive to zolpidem, suggesting a signiﬁcant proportion of
a5GABAAR. Furthermore, the gabazine-insensitive current was
markedly enhanced following burst stimulation of Schaffer collat-
erals. Finally, we conﬁrmed the speciﬁcity of L-655,708 on GABAA,SC
and the gabazine-insensitive currents by recording from WT and
gabra5/ mice.
IPSCs recorded in CA1 pyramidal neurons evoked by local
stimulationat the SRwere likelygeneratedbyperisomatic targeting
interneurons, including basket cells (Ouardouz and Lacaille, 1997).
This GABAA,local current had a sdecay of 163 ms at 0 mV. In experi-
ments designed to study Schaffer collateral-stimulated currents,
the IPSCs decayed with a strikingly slow time constant (277 ms).
GABAA,local and GABAA,SC also showed signiﬁcantly different time-
to-peak, and 10e90% rise time. Previous studies have already
shown evidence for such fast and slow components of synaptic
inhibition (Pearce, 1993; Banks et al., 1998). Whereas there was no
signiﬁcant difference in latency between GABAA,local and GABAA,SC,
suggesting that stimulation at the SR could also trigger direct acti-
vation of interneurons, GABAA,SC(gz) also showed a longer latency,
suggesting that under these conditions, a delay in activation of
presynaptic interneurons contributed to the longer time-to-peak.
Several possible explanations could account for the late peak
and surprisingly slow decay of GABAA,SC compared to GABAA,local.
Firstly, using fast perfusion on excised patches from cells express-
ing recombinant receptors, it has been shown that subunit
composition can affect decay time (Tia et al., 1996; Burgard et al.,
1999). Secondly, the time course of GABA concentration at therelease sites would affect the response kinetics, for example the rise
time responses for extrasynaptic receptors could be slowed down
as has been suggested for glutamatergic synapses (Scimemi et al.,
2004). Thirdly, long exposure to GABA, either in the synaptic cleft or
in extrasynaptic space, could produce the reactivation of synaptic
receptors as previously shown by modifying GABA uptake kinetics
(Roepstorff and Lambert, 1994). Recent studies using somatic
recordings in anatomically-identiﬁed connected cell pairs suggest
that the time course of inhibitory responses can indeed be deter-
mined both by subunit composition and by distinct transmitter
release transients (Szabadics et al., 2007; Ali and Thomson, 2008),
but we cannot exclude the possibility that dendritic ﬁltering
contributes to the slow kinetics as recorded at the soma. A further
possibility with potential physiological signiﬁcance is that the slow
rise and decay kinetics we observed for GABAA,SC is due to the
pattern of activation of GABAergic interneurons. For example, late-
ﬁring dendritic targeting interneurons have been shown to
generate slow GABAergic events in CA1 pyramidal neurons (Mac-
caferri and Dingledine, 2002). Furthermore, bursts of GABA release
produced by several action potentials or slow asynchronous release
(Hefft and Jonas, 2005) could contribute to slow kinetics.
GABAA,SC and GABAA,local showed different sensitivities to
gabazine. We consistently found that approximately 20% of GABAA,
SC charge transfer evoked by single stimulation was insensitive to
1 mM gabazine, and this fraction increased to w50% when using
burst stimulation. We interpreted this ﬁnding as an indication of
a component mediated by a5GABAARs as it has been previously
shown that the tonic current mediated by these is not sensitive to
1 mM gabazine (Bai et al., 2001; Caraiscos et al., 2004). We obtained
further evidence that a5GABAARs are activated by Schaffer
collateral stimulation by studying the effects of L-655,708 on the
isolated GABAAR components described above. GABAA,SC(gz)
produced either by single or burst stimulation was reduced by 30%
and there was no signiﬁcant difference in the amount of reduction
using either type of stimulation (P ¼ 0.27) as would be expected if
in both cases the synaptically evoked current is mediated by
a similar proportion of a5GABAARs. L-655,708 also produced
a signiﬁcant but smaller effect on GABAA,SC and GABAA,local. In
previous studies, spontaneous GABAA,local currents were found not
to contain an a5GABAAR-mediated component (Caraiscos et al.,
2004; Glykys and Mody, 2006; Zarnowska et al., 2009), however, it
is likely that the sorting of populations of spontaneous IPSCs by
their decay time for analysis could limit the detection of a slow
component in GABAA,local currents. Furthermore, it is likely that the
extracellular stimulation used to produce GABAA,local under our
experimental conditions would recruit interneurons other than
perisomatic targeting interneurons. It is also possible that gabazine,
as a competitive antagonist, could be displaced from GABAA
receptors by released GABA under our recording conditions for
GABAA,SC(gz). Although we do not have evidence to discard this
possibility, the effects of 20 nM L-655,708 on GABAA,SC in both rat
andmouse recordings without the use of gabazine strongly support
a speciﬁc a5GABAAR-mediated component.
We corroborated the speciﬁcity of 20 nM L-655,708 on GABAA,SC
and GABAA,SC(gz) currents using gabra5/mice andWT littermate
controls. There was a one third reduction in the GABAA,SC and
GABAA,SC(gz) currents from initial control values following appli-
cation of L-655,708 in WT mice, and no signiﬁcant reduction in
gabra5/ mice. In vitro analysis of L-655,708 activity on recombi-
nant human GABAARs showed a maximum inhibition of 20% of the
a5GABAAR current (Atack et al., 2006). Consistent with this we
found in both rat and mouse recordings that 20 nM L-655,708
inhibited approximately 30% of GABAA,SC(gz).
As a ﬁnal test to probe the composition of GABAARs mediating
the early and late components of inhibition, we used 400 nM
M. Vargas-Caballero et al. / Neuropharmacology 58 (2010) 668e675674zolpidem which is a highly potent and selective benzodiazepine,
with a5GABAAR sparing properties (a5GABAAR, Ki > 15 mM,
reviewed in Sieghart, 1995). GABAA,local was markedly enhanced
after application of zolpidem with a three fold increase in charge
transfer compared to GABAA,SC(gz). In comparison, GABAA,SC
showed only a two fold increase compared to GABAA,SC(gz). We
interpret this result to suggest that local stimulation in SR near SP
in the absence of fast synaptic excitation mostly activates peri-
somatic targeting interneurons, which selectively activate a1, a2
and a3GABAARs (Thomson et al., 2000), and that activation of
Schaffer collaterals not only stimulates perisomatic targeting cells
but also dendritic targeting interneurons, some of which speciﬁ-
cally target a5GABAARs. Therefore, the combined results using
400 nM zolpidem and 20 nM L-655,708 suggest that GABAA,SC
contains a signiﬁcant population of a5GABAARs. Thus, the present
observations highlight the strong activation of a5GABAARs
following Schaffer collateral stimulation in the hippocampus and
the pharmacological analysis of GABAA,SC(gz) suggests a particu-
larly robust activation during bursting activity.
Our results are consistent with previous suggestions that slow
inhibition is mediated by a speciﬁc subpopulation of interneurons
and molecularly distinct receptors (Banks et al., 1998; Pearce, 1993;
Zarnowska et al., 2009). The widespread localisation of a5GABAARs
at dendritic sites (Sperk et al., 1997) suggests that they are involved
in gating dendritic excitability, for example they could be involved
in regulating the generation of dendritic spikes such as those
observed in vivo during sharp waves (Kamondi et al., 1998).
Furthermore, the time course similarity of GABAA,SC and GABAA,
SC(gz) to the decay kinetics of NMDA receptors (Vicini et al., 1998)
makes themwell suited for inhibition of the induction of long-term
potentiation by providing a shunting inhibitory effect on the
NMDAR current (Staley and Mody, 1992).
The higher acquisition rate in associative memory tasks
observed in mice after systemic application of the inverse-agonist
L,655,708 or in gabra5/mice could be the expression of plasticity
produced by enhanced dendritic excitation. In order to understand
the cellular and network mechanisms that lead to enhanced
learning after reduction of a5GABAARs function it will be necessary
to study the requirement for activation/silencing of inputs targeting
a5GABAARs on hippocampal pyramidal neurons by afferent inputs
to the hippocampus and their timing in relation to the timing of
somatic and dendritic spikes. Here we provide evidence of activity
pattern-dependent feed-forward activation of a5GABAARs in CA1.
Testing the role of a5GABAARs in controlling the generation of
dendritic spikes or in the ﬁne tuning of long-term potentiation
awaits the broader availability of more potent and selective drugs
acting on a5GABAARs, such as RO4938581 (Ballard et al., 2009) or
the speciﬁc activation of a5GABAAR-targeting interneurons in vivo.
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